|
SETD1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.855800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.906000E-01 |
| Normal-vs-Stage2 |
7.743400E-01 |
| Normal-vs-Stage3 |
2.011000E-01 |
| Normal-vs-Stage4 |
6.872800E-01 |
| Stage1-vs-Stage2 |
5.965800E-01 |
| Stage1-vs-Stage3 |
7.818400E-02 |
| Stage1-vs-Stage4 |
7.286000E-01 |
| Stage2-vs-Stage3 |
4.349800E-01 |
| Stage2-vs-Stage4 |
5.670400E-01 |
| Stage3-vs-Stage4 |
2.668200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.721400E-01 |
| Normal-vs-AfricanAmerican |
3.799400E-01 |
| Normal-vs-Asian |
9.557200E-01 |
| Caucasian-vs-AfricanAmerican |
3.957400E-01 |
| Caucasian-vs-Asian |
9.333200E-01 |
| AfricanAmerican-vs-Asian |
7.115800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.754800E-01 |
| Normal-vs-Female |
5.246400E-02 |
| Male-vs-Female |
1.772260E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.720000E-01 |
| Normal-vs-Extreme_Weight |
3.202200E-01 |
| Normal-vs-Obese |
1.099590E-01 |
| Normal-vs-Extreme_Obese |
6.592400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.848200E-01 |
| Normal_Weight-vs-Obese |
1.076020E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.721000E-01 |
| Extreme_Weight-vs-Obese |
1.473600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.497800E-01 |
| Obese-vs-Extreme_Obese |
8.004400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.715500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.272200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.079600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.249240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.836400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.093700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.285770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.760500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.732000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.214600E-01 |
| Normal-VS-Type2 PRCC |
1.581850E-02 |
| Normal-VS-KIRP CIMP |
3.526600E-01 |
| Normal-VS-Unclassified PRCC |
3.350200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.002750E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.752800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.548300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.495800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.997200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.663800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.928550E-01 |
| Normal-vs-N1 |
9.208200E-02 |
| Normal-vs-N2 |
8.832000E-01 |
| N0-vs-N1 |
2.030300E-02 |
| N0-vs-N2 |
7.095600E-01 |
| N1-vs-N2 |
4.219400E-01 |
|
|
